Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? Letter

Kruser, Tim J, Mehta, Minesh P, Kozak, Kevin R. (2016). Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma-An Easy Question Turned Difficult: Treat the Scan or the Patient? . JOURNAL OF CLINICAL ONCOLOGY, 34(11), 1281-+. 10.1200/JCO.2015.64.7883

keywords

  • CEDIRANIB
  • Life Sciences & Biomedicine
  • NEWLY-DIAGNOSED GLIOBLASTOMA
  • Oncology
  • RADIOTHERAPY
  • SURVIVAL
  • Science & Technology
  • TEMOZOLOMIDE
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 1281

end page

  • +

volume

  • 34

issue

  • 11